6 April

Biotech company BD and BioGX have received Emergency Use Authorization (EUA) from the US Food and Drug Administration (FDA) for a Covid-19 diagnostic test. This test will aid hospitals in screening for coronavirus at the hospital, with results expected within three hours. The test will be carried out on a molecular diagnostic platform, the BD MAX System. This platform is used at many laboratories around the country. Each unit can analyse hundreds of samples each day.

Leica Biosystems has received approval from FDA to use its Aperio ImageScope DX Viewer for remote diagnosis in emergencies amid the COVID-19 pandemic. The Aperio AT2 DX Scanner presents the images on the Aperio ImageScope DX Viewer, which will aid pathologists to view and diagnose cases from other locations. Read the full story here.

MG Motor India has initiated talks with three medical device makers for production of ventilators to keep up with the demand amid the Covid-19 pandemic. LiveMint quoted a top company official as saying that the ventilators will be produced at the Halol facility. MG Motor India had previously introduced a challenge for the hunt for a low-cost ventilator design. It is also in the process of developing its own ventilator to begin due to shortages in the country. It expects the prototype to be ready in a week.

Medical imaging software company VUNO has joined the global coalition to aid in addressing the major issues faced by the international healthcare community due to Covid-19 pandemic with the help of AI. The company has offered its AI solutions, VUNO Med – LungQuant and VUNO Med-Chest X-ray: COVID-19, which cover lung X-ray and CT modalities respectively. With the AI solutions, users can opt for one or both the algorithms in one website and do not need to move between different AI systems.